- Anyone developing methods for elemental analysis, for example using ICP, AAS or XRF
- Anyone developing pharmaceutical formulations
- Anyone producing or setting specifications for pharmaceutical raw materials or intermediates
- how XRF works and what can be expected
- about typical applications of XRF for the pharmaceutical industry and how this compares to techniques such as inductively-coupled plasma (ICP) and atomic absorption spectroscopy (AAS).
Successful elemental analysis for the pharmaceutical industry, using benchtop XRF
September 28, 2022 | 15:30-16:30 BST | Virtual
About The Event
Setting meaningful and realistic specifications for pharmaceutical product Critical Material Attributes (CMAs) is important in ensuring a product meets its target performance profile and is safe. Within this, control of elemental impurities is vital as these do not provide therapeutic benefit to the patient and may even cause an adverse effect. Join us for a live demonstration of the Epsilon, and discover how easy and straightforward X-ray Fluorescence (XRF) spectroscopy can be for elemental analysis for pharmaceutical intermediates and final dosage forms. You will also learn why elemental analysis is required. We will review the guidance provided in ICH Q3D, which recommends analysis of elements which may be present as impurities. These impurities are either from processing or raw materials, or may have been intentionally added during processing - such as heavy metal catalyst materials. We will then show you how XRF can be applied for rapid characterization of pharmaceutical intermediates and dosage forms.
More Information
Who should attend?
What will you learn?